However, the experts were not convinced and decided not to put it in
the revised treatment protocol," a person aware of the matter told ET
on condition of anonymity.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/favirpiravir-yet-to-find-favour-with-icmr/articleshow/76717788.cms
No comments:
Post a Comment